Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator‐activated receptors (PPAR) are novel nuclear receptors and PPARγ ligands have been shown to produce pro‐apoptotic effects in many cancer cell types, including colon cancer. PPARγ ligands exert their effect through PPARγ‐dependent (genomic) and PPARγ‐independent (non‐genomic) mechanisms. Recent evidence suggests that PPARγ ligands exert their pro‐apoptotic effects in part by directly antagonizing the NF‐κβ pathway as well as through activation of the MAP kinase pathway. In this report, we have demonstrated that ciglitazone, a member of the thiazoldinedione class of PPARγ ligands induces HT‐29 colon cancer cells to undergo apoptosis and prior to apoptosis, ciglitazone exposure results in a transient phosphorylation of PPARγ. This phosphorylation of PPARγ was mediated through the ciglitazone‐induced activation of Erk1/2. PPARγ phosphorylation affected the genomic pathway by being inhibitory to PPARγ–DNA binding and PPRE transcriptional activity, as well as the non‐genomic pathway by increasing the physical interaction of PPARγ with p65, leading to the inhibition of NF‐κβ. Ciglitazone induced phosphorylation of PPARγ through the MAP kinase pathway provides a potential regulatory mechanism for PPARγ's physical interaction with p65, leading to inhibition of NF‐κβ and subsequent apoptosis. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956 · cited 2×
“PPARb is ubiquitously expressed in most tissues, while PPARg is expressed in adipose tissues and enterocytes [Kersten et al., 2000].”
BackgroundDelerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · cited 1×
“Some studies suggest that the PPARinduced inhibition of NF-kb is through modulation of the IkB pathway, while others suggest that this inhibition is through direct physical interaction of PPARwithNF-kb [Delerive et al., 1999; Chung et al., 2000] and these two pathways may not be mutually exclusive.”
BackgroundPPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Cited by
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors
Korbecki, J., Bobiński, R., & Dutka, M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01231-1 · Cited by 415
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., & Russo, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.033 · Cited by 275
Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
P. Menendez-Gutierrez, M., Roszer, T., & Ricote, M. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436669 · Cited by 62
Metadata
- Authors
- Chen, F., Wang, M., O'Connor, J. P., He, M., Tripathi, T., & Harrison, L. E.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2003-10-07
- Volume
- 90
- Issue
- 4
- Pages
- 732-744
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2136644969
- Cited by
- 151
- References
- 4
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ. https://app.cochat.ai/papers/10.1002/jcb.10668
- The paper
- Chen, F., Wang, M., O'Connor, J. P., He, M., Tripathi, T., & Harrison, L. E. (2003). Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.10668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.